iSWAM Jakarta 2025: EG Bio Advances Strategic Expansion in Indonesia and ASEAN

From December 5 to 7, 2025, EG Bio participated in iSWAM Jakarta 2025 alongside Genèse Labs France, advancing its strategic expansion in Indonesia and ASEAN markets.

iSWAM (International Symposium on Aesthetic Medicine) typically hosts 2,500+ doctors, 150+ exhibitors, and participants from across the Asia-Pacific region, making it a key congress for professional aesthetic medicine.

At iSWAM Jakarta 2025, EG Bio and Genèse Labs France showcased advanced regenerative and injectable innovations, engaging with Indonesian and ASEAN distributors on market access strategies, regulatory considerations, and long-term cooperation.

About EG Bio

EG Bio Co., Ltd. is a global B2B supplier and distribution partner specializing in professional aesthetic products. The company works with selected international brands and manufacturers to support structured global distribution, market development, and long-term partnerships across multiple regions.

EG Bio focuses on exclusive distribution models, portfolio expansion, and international market access, providing distributors and professional partners with reliable supply, clear positioning, and sustainable growth opportunities.

About Genèse Labs France

Genèse Labs France is a France-based company focused on the development and management of aesthetic and dermocosmetic product portfolios for professional markets. The company works with selected manufacturing and distribution partners to support structured international expansion, emphasizing product quality, regulatory alignment, and long-term brand development.

Genèse Labs France positions its products for global markets through strategic partnerships, ensuring clear brand ownership, consistent positioning, and sustainable growth across multiple regions.